What is the intrinsic value of MCRB?
As of 2025-04-26, the Intrinsic Value of Seres Therapeutics Inc (MCRB) is
0.08 USD. This MCRB valuation is based on the model Peter Lynch Fair Value.
With the current market price of 10.08 USD, the upside of Seres Therapeutics Inc is
-99.23%.
Is MCRB undervalued or overvalued?
Based on its market price of 10.08 USD and our intrinsic valuation, Seres Therapeutics Inc (MCRB) is overvalued by 99.23%.
MCRB Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
0.08 - 0.08 |
0.08 |
-99.23% |
| P/E |
0.74 - 1.22 |
0.98 |
-90.3% |
| DDM - Stable |
0.09 - 0.30 |
0.19 |
-98.1% |
| DDM - Multi |
0.10 - 0.29 |
0.15 |
-98.5% |
MCRB Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
87.90 |
| Beta |
0.88 |
| Outstanding shares (mil) |
8.72 |
| Enterprise Value (mil) |
57.10 |
| Market risk premium |
4.60% |
| Cost of Equity |
12.60% |
| Cost of Debt |
5.00% |
| WACC |
8.13% |